FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2563367340> ?p ?o ?g. }

• W2563367340 endingPage "S2" @default.
• W2563367340 startingPage "S2" @default.
• W2563367340 abstract "Gene correction is an ideal gene therapy strategy for hereditary disease, including sickle cell disease. Recently, the CRISPR/Cas9 system was developed to allow site-specific DNA breakage, which can enhance homologous recombination-based gene correction with template DNA. However, efficient delivery remains crucial for successful genome editing. In this work, we sought to develop a new gene/protein delivery system with lentiviral vectors for efficient genome editing. We first used an HIV-1 based lentiviral vector system to deliver the CRISPR/Cas9 system including guide RNAs and the Cas9 endonuclease since efficient delivery in various cells, including hematopoietic stem cells, has previously been established. However, using this system, the guide RNA/Cas9-transduced cells continuously express the Cas9 endonuclease, increasing the likelihood of off target effects. In addition, the large size of the Cas9 DNA (4.3kb) limits efficient lentiviral packaging, likely reducing transduction efficiency. Therefore, we sought to develop a Cas9 protein delivery system with lentiviral particles that did not integrate the Cas9 DNA. Cyclosphilin A (CypA) has a function to bind to lentiviral capsids; thus, we hypothesized that fusion proteins between Cas9 and CypA could be packaged in lentiviral particles to allow delivery. We designed two Cas9/CypA fusion proteins: “CypA to Cas9” and “Cas9 to CypA”, and we prepared the lentiviral vectors encoding a GFP-targeting guide RNA with the fusion proteins. We transduced a GFP+ stable cell line with GFP-targeting guide RNA vector containing Cas9 fusion proteins. At 14 days after transduction, GFP-positivity (%GFP) was reduced with both Cas9 protein delivery vectors (48-53%, p<0.01), as compared to a guide RNA alone vector control (83%) and no transduction control (83%). The disruption of GFP was comparable to a guide RNA/Cas9 integrating vector (40%). These data suggest that Cas9/CypA fusion proteins can be delivered with lentiviral particles, and the Cas9 fusion proteins have an endonuclease function to efficiently induce a GFP DNA break. To model DNA correction, we then designed a Cas9 protein delivery non-integrating lentiviral vector encoding both GFP-targeting guide RNA and YFP gene template, which contains all essential components for GFP to YFP gene correction in one vector. Conversion of GFP to YFP would thus model gene correction. Silent mutations in the target site in YFP template were required to produce the gene correction vector. We transduced a GFP+ stable cell line with the gene correction vector using the Cas9/CypA fusion protein or Cas9 protein alone control (without CypA fusion). We observed a significant reduction of GFP positivity (20-24% GFP, p<0.01) along with high rates of conversion to YFP positivity (29-30%, p<0.01) among all Cas9 protein delivery vectors, even with Cas9 protein alone control, as compared to no Cas9 control (YFP 4.9%) and no transduction control (YFP 4.3%). The GFP to YFP gene correction was confirmed by DNA sequencing. These data suggest that Cas9 protein alone can be delivered with lentiviral particles and the Cas9 protein delivery system (with or without CypA fusion) allows for efficient one-time gene correction with non-integrating vectors encoding both guide RNA and template. Additionally, we transferred guide RNA and YFP template again 6 days after Cas9 protein delivery; however, no increase of %YFP was observed, suggesting that Cas9 function was lost over the short term (<6 days). In summary, we developed Cas9 protein delivery system with lentiviral vectors, which resulted in efficient GFP gene breakage. The Css9 protein delivery system allowed for efficient one-time GFP to YFP gene correction with non-integrating lentiviral vector encoding both guide RNA and template DNA. Our findings improve the prospects for efficient delivery and safe genome editing." @default.
• W2563367340 created "2017-01-06" @default.
• W2563367340 creator A5001134935 @default.
• W2563367340 creator A5009555865 @default.
• W2563367340 creator A5028422235 @default.
• W2563367340 creator A5067082646 @default.
• W2563367340 creator A5080459253 @default.
• W2563367340 creator A5087152657 @default.
• W2563367340 date "2016-05-01" @default.
• W2563367340 modified "2023-09-26" @default.
• W2563367340 title "3. Development of a Cas9 Protein Delivery System with Lentiviral Vectors for RNA-Guided Genome Editing" @default.
• W2563367340 doi "https://doi.org/10.1016/s1525-0016(16)32812-x" @default.
• W2563367340 hasPublicationYear "2016" @default.
• W2563367340 type Work @default.
• W2563367340 sameAs 2563367340 @default.
• W2563367340 citedByCount "0" @default.
• W2563367340 crossrefType "journal-article" @default.
• W2563367340 hasAuthorship W2563367340A5001134935 @default.
• W2563367340 hasAuthorship W2563367340A5009555865 @default.
• W2563367340 hasAuthorship W2563367340A5028422235 @default.
• W2563367340 hasAuthorship W2563367340A5067082646 @default.
• W2563367340 hasAuthorship W2563367340A5080459253 @default.
• W2563367340 hasAuthorship W2563367340A5087152657 @default.
• W2563367340 hasBestOaLocation W25633673401 @default.
• W2563367340 hasConcept C104317684 @default.
• W2563367340 hasConcept C111599444 @default.
• W2563367340 hasConcept C123894998 @default.
• W2563367340 hasConcept C132455925 @default.
• W2563367340 hasConcept C135983454 @default.
• W2563367340 hasConcept C144501496 @default.
• W2563367340 hasConcept C15152581 @default.
• W2563367340 hasConcept C32470452 @default.
• W2563367340 hasConcept C40767141 @default.
• W2563367340 hasConcept C54355233 @default.
• W2563367340 hasConcept C55493867 @default.
• W2563367340 hasConcept C70721500 @default.
• W2563367340 hasConcept C86803240 @default.
• W2563367340 hasConcept C97702854 @default.
• W2563367340 hasConcept C98108389 @default.
• W2563367340 hasConceptScore W2563367340C104317684 @default.
• W2563367340 hasConceptScore W2563367340C111599444 @default.
• W2563367340 hasConceptScore W2563367340C123894998 @default.
• W2563367340 hasConceptScore W2563367340C132455925 @default.
• W2563367340 hasConceptScore W2563367340C135983454 @default.
• W2563367340 hasConceptScore W2563367340C144501496 @default.
• W2563367340 hasConceptScore W2563367340C15152581 @default.
• W2563367340 hasConceptScore W2563367340C32470452 @default.
• W2563367340 hasConceptScore W2563367340C40767141 @default.
• W2563367340 hasConceptScore W2563367340C54355233 @default.
• W2563367340 hasConceptScore W2563367340C55493867 @default.
• W2563367340 hasConceptScore W2563367340C70721500 @default.
• W2563367340 hasConceptScore W2563367340C86803240 @default.
• W2563367340 hasConceptScore W2563367340C97702854 @default.
• W2563367340 hasConceptScore W2563367340C98108389 @default.
• W2563367340 hasLocation W25633673401 @default.
• W2563367340 hasOpenAccess W2563367340 @default.
• W2563367340 hasPrimaryLocation W25633673401 @default.
• W2563367340 hasRelatedWork W2008719138 @default.
• W2563367340 hasRelatedWork W2321055517 @default.
• W2563367340 hasRelatedWork W2563367340 @default.
• W2563367340 hasRelatedWork W2607137613 @default.
• W2563367340 hasRelatedWork W2804064057 @default.
• W2563367340 hasRelatedWork W2944986861 @default.
• W2563367340 hasRelatedWork W3080086069 @default.
• W2563367340 hasRelatedWork W3110809460 @default.
• W2563367340 hasRelatedWork W3134049475 @default.
• W2563367340 hasRelatedWork W3164404986 @default.
• W2563367340 hasVolume "24" @default.
• W2563367340 isParatext "false" @default.
• W2563367340 isRetracted "false" @default.
• W2563367340 magId "2563367340" @default.
• W2563367340 workType "article" @default.